343 results on '"Reverter, Juan"'
Search Results
2. Predicting portal thrombosis in cirrhosis: A prospective study of clinical, ultrasonographic and hemostatic factors
3. Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study
4. Discursos leídos ante la Real Academia de Ciencias Exactas, Físicas y Naturales en la recepción pública del sr. Juan Navarro Reverter el día 6 de mayo de 1894
5. Total Circulating Microparticle Levels After Laparoscopic Surgical Treatment for Endometrioma: A Pilot, Prospective, Randomized Study Comparing Stripping with CO2 Laser Vaporization
6. Hemicolectomy in a patient with aortic valve disease: Case report
7. Hemicolectomía en un paciente con valvulopatía aórtica: reporte de caso
8. Increased circulating cell-derived microparticle count is associated with recurrent implantation failure after IVF and embryo transfer
9. Enoxaparin reduces hepatic vascular resistance and portal pressure in cirrhotic rats
10. Additional file 1 of Haemostasis patterns in patients with acute-on-chronic liver failure and acute decompensation of cirrhosis including thromboelastometric tests with and without the addition of Protac: a pilot study
11. Hypercoagulability in Patients With Chronic Noncirrhotic Portal Vein Thrombosis
12. Effects of Raloxifene on Endothelial Function and Hemostasis in Women With Ischemic Heart Disease
13. Efecto del raloxifeno en la función endotelial y la hemostasia en mujeres con enfermedad coronaria
14. Haemostasis Patterns in Patients With Acute-on-chronic Liver Failure and Acute Decompensation of Cirrhosis Including Thromboelastometric Tests With and Without the Addition of Protac: a Pilot Study
15. Incidence and factors predictive of recurrent thrombosis in patients with non-cirrhotic portal vein thrombosis
16. Clot lysis time and thrombin activatable fibrinolysis inhibitor in severe preeclampsia with or without associated antiphospholipid antibodies
17. MODELO PRACTICO PARA LA FIJACION DEL PRECIO EN LA EMPRESA PUBLICA
18. In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation
19. Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis
20. Antiphospholipid antibodies may impair factor XIIa-dependent activation of fibrinolysis in pregnancy:: in vitro evidence with human endothelial cells in culture and monoclonal anticardiolipin antibodies
21. Impaired factor XIIa–dependent activation of fibrinolysis in treated antiphospholipid syndrome gestations developing late-pregnancy complications
22. Risk of thromboembolic events after recurrent spontaneous abortion in antiphospholipid syndrome: a case–control study
23. Von Willebrand factor levels predict clinical outcome in patients with cirrhosis and portal hypertension
24. Reduced plasma fibrinolytic potential in patients with recurrent implantation failure after IVF and embryo transfer
25. A hypercoagulable state does not play a major role in the development of portal vein thrombosis in patients with cirrhosis
26. Thrombin Activatable Fibrinolysis Inhibitor and Clot Lysis Time in Pregnant Patients with Antiphospholipid Syndrome: Relationship with Pregnancy Outcome and Thrombosis
27. Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: Relationship with thrombosis occurrence and JAK2 V617F allele burden
28. Pregnancy-Associated Plasma Protein-A Levels Are Related to Glycemic Control but Not to Lipid Profile or Hemostatic Parameters in Type 2 Diabetes
29. Increased CD11b neutrophil expression in Budd–Chiari syndrome or portal vein thrombosis secondary to polycythaemia vera
30. Increased local procoagulant action: a mechanism contributing to the favorable hemostatic effect of recombinant FVIIa in PLT disorders
31. Linfocitos T y monocitos activados en la reestenosis coronaria. ¿Reflejan la persistencia de un mecanismo inflamatorio?
32. Congenital antithrombin deficiency in patients with splanchnic vein thrombosis
33. Study of Biocompatibility of Membranes in Online Hemodiafiltration
34. FRI-439-Factor V and VIII may predict the risk of recurrent splanchnic thrombosis in patients with non-cirrhotic chronic portal vein thrombosis of local and idiopathic etiology not receiving anticoagulation
35. FRI-423-Role of antithrombin deficiency in splanchnic vein thrombosis
36. TIPS is a useful long-term derivative therapy for patients with Budd-Chiari syndrome uncontrolled by medical therapy
37. UTILITY OF BONE MARROW AND LIVER BIOPSIES FOR STAGING CUTANEOUS T-CELL LYMPHOMA
38. Bone marrow assessment in B-cell chronic lymphocytic leukaemia: aspirate or biopsy? A comparative study in 258 patients
39. Las Palmas III — the success story of brine staging
40. Study of Biocompatibility of Membranes in Online Hemodiafiltration.
41. Coagulation Failure in Patients With Acute‐on‐Chronic Liver Failure and Decompensated Cirrhosis: Beyond the International Normalized Ratio
42. Assessment of Potential Thrombogenicity of Coagulation Factor IX Concentrates in an in Vitro Model of Human Thrombogenesis
43. Ex vivo response to aspirin differs in stroke patients with single or recurrent events: a pilot study
44. SAT127 - A hypercoagulable state does not play a major role in the development of portal vein thrombosis in patients with cirrhosis
45. NOVEL PROTHROMBOTIC AND GENETIC RISK FACTORS IN ACUTE MYOCARDIAL INFARCTION: IMPLICATIONS FOR MID- AND LONG-TERM SECONDARY PREVENTION
46. Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency.
47. Total Circulating Microparticle Levels After Laparoscopic Surgical Treatment for Endometrioma: A Pilot, Prospective, Randomized Study Comparing Stripping with CO2 Laser Vaporization.
48. Non-detectable Chlamydophila pneumoniae DNA in peripheral leukocytes in type 2 diabetes mellitus patients with and without carotid atherosclerosis
49. Reply
50. Thrombin activatable fibrinolysis inhibitor and clot lysis time in women with recurrent miscarriage associated with the antiphospholipid syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.